The Center for Cancer Systems Pharmacology

CRS fellowship opportunity in Pediatric Real-World Evidence research
LEARN MORE

Improving the Process of Therapeutic Development

Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.

More

Featured Publications

Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance
Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance
Everhart, AO, Sen S, Stern AD et al., 2023
Validation of Predictive Analyses for Interim Decisions in Clinical Trials
Validation of Predictive Analyses for Interim Decisions in Clinical Trials
Avalos-Pacheco A, Ventz S, Arfè A, et al., 2023
Evidence from ClinicalTrials.gov on the growth of Digital Health Technologies in neurology trials
Evidence from ClinicalTrials.gov on the growth of Digital Health Technologies in neurology trials
Masanneck, L, Gieseler P, Gordon WJ et al., 2023

The Regulatory Science Fellowship Program

Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.

MORE

News, Events, & Updates

Thank you for joining us for CRS events in this academic year. Stay tuned for exciting seminars and workshops starting in the Fall!

Partners